Loading...
NPI 1639261407 · Garden City, NY · Ambulatory Surgical Clinic/Center
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Endo Group, LLC is a ambulatory surgical clinic/center provider located in Garden City, New York. This profile covers 8 Medicare and 1 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Endo Group, LLC |
| Address | 400 Endo Blvd |
| City | Garden City |
| State | NY |
| ZIP | 11530 |
| Taxonomy | Ambulatory Surgical Clinic/Center |
| NPI Enumerated | September 29, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $3.7M |
| Medicaid | $1.4M |
ENDO GROUP, LLC operates as an ambulatory surgical clinic with a clear ophthalmic focus: its Medicare and Medicaid billing is dominated by cataract extraction and intraocular lens implantation procedures (notably codes 66984, 66982, 66991), plus related anterior-segment glaucoma procedures and ophthalmic irrigation (e.g., 65820, 65855, J1097). The procedure descriptions and the mix of high-volume cataract codes indicate the site is structured to deliver same-day surgical care for cataract and some glaucoma interventions rather than broad multispecialty outpatient services.
Revenue is highly concentrated on Medicare: the precomputed top 3 Medicare codes account for 92.2% of the provider’s total Medicare revenue, with code 66984 alone representing $3M of Medicare revenue (3.1K claims, $979 avg paid/claim) and 81.3% of the provider’s Medicare receipts. This concentration signals that a single cataract procedure is the core revenue driver for their Medicare business.
Medicaid revenue is effectively single-procedure dependent: the precomputed top 3 Medicaid codes account for 100.0% of Medicaid revenue, and code 66984 accounts for all reported Medicaid revenue ($1.4M, 1.4K claims, $1018 avg paid/claim). That pattern makes the provider effectively single-payer-per-procedure on Medicaid and exposes Medicaid volumes to changes in reimbursement or referral patterns for that one service.
The provider’s payer mix favors Medicare in scale: Medicare revenue ($3.7M) is materially larger than Medicaid revenue ($1.4M), indicating Medicare represents the primary payer base by dollars though Medicaid is a non-trivial contributor to overall volume via the same dominant cataract code. Analysts should therefore prioritize Medicare performance and utilization trends when modeling near-term revenue risk or growth.
On competitive standing, ENDO GROUP shows national prominence for code 66984: the provider ranks #468 of 15965 nationally (97th percentile) and is labeled "notably above typical national volume for this code," indicating it is a major national producer of routine extracapsular cataract extraction with lens insertion. Other Medicare codes tied to its service line (66982 and 66991) show presence but are much smaller revenue contributors ($211.7K and $192.1K respectively) even though 66982 is ranked #72 of 4580 (98th percentile; dataset labels it "typical, unremarkable volume") and 66991 ranks #202 of 1445 (86th percentile; "typical, unremarkable volume").
Within state Medicaid competition, the provider holds an upper-tier position for 66984: it ranks #20 of 156 in-state (88th percentile; labeled "typical, unremarkable volume"). This suggests the clinic is a significant but not uniquely dominant Medicaid cataract provider in New York, with strong Medicaid cataract volume relative to most in-state peers.
Service-line breadth beyond cataract procedures is limited: several ancillary ophthalmic codes appear at low absolute revenue (for example, 66821 at $50.1K, J1097 at $108.5K, 65820 at $114.5K), which implies the center’s additional glaucoma- or laser-based services are complementary but not material revenue drivers. These smaller lines may support integrated perioperative care for cataract patients rather than representing distinct high-volume profit centers.
The practice shows long-term operational stability with an NPI enumerated on 2006-09-29 (~20 years ago), supporting the interpretation that its high-volume cataract throughput is established rather than a short-term surge; this tenure should be factored into network contracting and competitive analyses.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
8 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 66984 | The provider inserts an artificial lens after removing an extracapsular cataract by aspiration or use of ultrasonic waves. This procedure is done without the use of an endoscopic laser probe to… | 3,090 | $980 | $3M |
| 66982 | The provider inserts an intraocular lens prosthesis after extracapsular cataract extraction using complex techniques and devices. He may perform this by means of an iris expansion device, providing… | 220 | $960 | $211.7K |
| 66991 | The provider inserts an intraocular lens prosthesis during the same session as extracapsular cataract extraction. The provider also inserts one or more anterior segment aqueous drainage devices in… | 70 | $2,960 | $192.1K |
| 65820 | The provider incises the limbus to improve drainage of aqueous humor in the eye. This procedure is typically performed on children, usually to treat congenital glaucoma. | 80 | $1,510 | $114.5K |
| J1097 | phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml | 1,430 | $80 | $108.5K |
| 66821 | The provider removes the haziness from the capsule of the eye using a laser for a patient with a secondary membranous cataract. | 210 | $240 | $50.1K |
| 65855 | In this procedure, the provider uses a laser to burn the trabecular meshwork, the tissue of mesh where the iris meets the sclera, to drain aqueous humor from the anterior chamber and treat glaucoma. | 90 | $120 | $9.9K |
| 65850 | The provider opens the trabecular meshwork to improve drainage of aqueous humor. | 10 | $560 | $7.3K |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 8 CPT/HCPCS codes.
View: State1 / 2
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
1 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 66984 | The provider inserts an artificial lens after removing an extracapsular cataract by aspiration or use of ultrasonic waves. This procedure is done without the use of an endoscopic laser probe to… | 1,370 | $1,020 | $1.4M |
How this provider's Medicaid billing volume and revenue compare to other New York providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. New York median
1 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 66984 | The provider inserts an artificial lens after removing an extracapsular cataract by aspiration or use of ultrasonic waves. This procedure is done without the use of an endoscopic laser probe to… | 20 | 160 | 140 | $720 | $423.8K |
Other providers in the same ZIP code as Endo Group, LLC, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Regioncare Inc. | NY | Home Health Agency | $0 | $96.6M |
| Bethpage Medical, PLLC | NY | Obstetrics & Gynecology Physician | $0 | $32M |
| Sco Family Of Services | NY | Foster Care Agency | $0 | $27.1M |
| Ann Anderson | NY | Clinical Pathology/Laboratory Medicine Physician | $5.2M | $0 |
| Endoscopy Center Of Long Island LLC | NY | Ambulatory Surgical Clinic/Center | $1.2M | $1.5M |
| Mark Fleckner | NY | Retina Specialist (Ophthalmology) Physician | $1.9M | $172.3K |
| Robin Ehrenpreis | NY | Diagnostic Radiology Physician | $1.6M | $0 |
| Paul Lang | NY | Nuclear Radiology Physician | $1.3M | $70.2K |
| Richard Jacaruso | NY | Cardiovascular Disease Physician | $1.1M | $0 |
| Carina Rizzo | NY | Dermatology Physician | $1.1M | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.